Team

The Rivkin Center's success is driven by a dedicated team of professionals who bring passion, expertise, and commitment to the fight against ovarian cancer. Our team comprises of leaders in medicine, research, and community engagement, all working collaboratively to advance our mission.

Leadership Team

MollyOConnor1

Molly O’Connor

CEO

Molly O’Connor leads the Rivkin Center with a vision rooted in innovation and impact. Her leadership ensures that the organization remains focused on advancing ovarian cancer research and support.

JackieLang23

Jackie Lang, PhD

Scientific Programs Director

Jackie Lang oversees the scientific initiatives of the Rivkin Center, ensuring that our research funding is directed towards projects with the greatest potential to make a difference.

Kim Isaac

Kim Isaac

Interim Development Director

Kim Isaac brings over 30 years of expertise in campaign management and donor relations. At the Rivkin Center, she focuses on advancing fundraising strategies to support ovarian cancer research.

Board of Directors

Our Board of Directors brings together a diverse group of individuals with a shared commitment to ending ovarian cancer. Their guidance and oversight are crucial to the Rivkin Center’s strategic direction.

  • Melissa Rivkin, Board President
  • Amy P. Sing, MD, Board Vice President
  • Alex Smith, Secretary
  • Audrey L. Covner, DNP, JD, BSN, RN
  • Bob Mahler
  • Eva Corets
  • Fernanda Musa, MD
  • Katerie Laughlin Schei, Past Board President
  • Katie Van Kessel, MD, OB/GYN
  • Kristin Hawes
  • Thomas Brown, MD
  • Eddie Fisher – Emeritus
  • Saul E. Rivkin, MD – Emeritus

Scientific Advisory Board

Our Scientific Advisory Board comprises leading experts in ovarian cancer research, guiding the Rivkin Center’s scientific initiatives and ensuring that our funding supports the most promising projects.

  • Mary L. (Nora) Disis, MD
    Associate Dean for Translational Health Sciences, University of Washington.
  • Neil Johnson, PhD
    Associate Professor of Molecular Therapeutics, Chase Cancer Center.
  • Ramandeep Rattan, MD
    Gynecologic Oncology Research Professor, Henry Ford Health.
  • Ursula A. Matulonis, MD
    Chief of Gynecologic Oncology, Dana-Farber Cancer Institute.
  • Weiping Zou, MD, PhD
    Director for Translational Research, University of Michigan.
  • Victoria Seewaldt, MD
    Professor of Medicine, Duke University.
  • Kunle Odunsi, MD, PhD
    Research Program Director of Gynecologic Oncology, Roswell Park Cancer Institute.